Alnylam Pharmaceuticals (NASDAQ:ALNY) reported its Q4 earnings results on Thursday, February 10, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Check out this: Insiders Buy Over $43M Of 4 Stocks
Earnings
Alnylam Pharmaceuticals missed estimated earnings by 9.74%, reporting an EPS of $-1.69 versus an estimate of $-1.54.
Revenue was up $94.97 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.06, which was followed by a 1.59% drop in the share price the next day.
Here's a look at Alnylam Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -1.57 | -1.6 | -1.75 | -1.76 |
| EPS Actual | -1.51 | -1.3 | -1.64 | -1.60 |
| Revenue Estimate | 218.69M | 193.18M | 168.74M | 146.07M |
| Revenue Actual | 187.63M | 220.55M | 177.57M | 163.56M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
